Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Oct 26:8:2050313X20969044.
doi: 10.1177/2050313X20969044. eCollection 2020.

Pulmonary tumor thrombotic microangiopathy presenting as recurrent syncope

Affiliations
Case Reports

Pulmonary tumor thrombotic microangiopathy presenting as recurrent syncope

Constanza Burciaga Calderoni et al. SAGE Open Med Case Rep. .

Abstract

Pulmonary tumor thrombotic microangiopathy is a rare condition in which embolization of tumor cells to the pulmonary arterioles causes fibrocellular intimal thickening and activation of the coagulation cascade resulting in pulmonary hypertension and right heart failure. Herein, we highlight a young 35-year-old male with no known past medical history who presented with recurrent syncope and dyspnea, and was found to have severe right heart failure and pulmonary hypertension. He developed sudden clinical deterioration and died after a cardiac arrest. Autopsy revealed poorly differentiated gastric adenocarcinoma and pulmonary tumor thrombotic microangiopathy. New onset severe pulmonary hypertension and right heart failure without any other obvious etiology should encourage the reader to evaluate for pulmonary tumor thrombotic microangiopathy and undergo a diligent search for underlying malignancy. This case highlights recurrent syncope as a rare presentation of this rapidly fatal disease.

Keywords: Pulmonary hypertension; cancer; pulmonary tumor thrombotic microangiopathy.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Chest Tomography showing subtle diffuse ground-glass (blue arrow) and multiple tree-in-bud opacities (red arrow) and enlarged right ventricle and right atrium.
Figure 2.
Figure 2.
H and E stain showing highly atypical cells causing fibroblastic intimal hypertrophy in the pulmonary vessels, consistent with pulmonary tumor thrombotic microangiopathy.
Figure 3.
Figure 3.
H and E stain showing highly atypical cells invading muscularis externa in the gastric wall.

References

    1. Von Herbay A, Illes A, Waldherr R, et al.. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer 1990; 66: 587–592. - PubMed
    1. Godbole RH, Saggar R, Kamangar N. Pulmonary tumor thrombotic microangiopathy: a systematic review. Pulm Circ 2019; 9(2): 851000. - PMC - PubMed
    1. D’Silva K, Vaidya A, Smithy JW, et al.. A rapid change in pressure. N Engl J Med 2020; 382: e8. - PubMed
    1. Price LC, Wells AU, Wort SJ. Pulmonary tumour thrombotic microangiopathy. Curr Opin Pulm Med 2016; 22: 421–428. - PubMed
    1. Task Force for the Diagnosis and Management of Syncope, European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009; 30(21): 2631–2671. - PMC - PubMed

Publication types

LinkOut - more resources